홈 > 연구소 > 논문 / 학술활동
연구소
마마파파&베이비의 핵심인 베이비 드림 난임 연구소는
그간의 연구학술 성과에 안주하지 않고,
늘 한계를 뛰어넘기 위해 노력합니다.
2013년 미국불임학회(ASRM) P-121 Effect of GnRH-antagonist versus agonist on embryo quality by comparing the outcomes of FETs. (동결란 이식에서 GnRH 길항제 요법과 효능제 요법이 수정란의 상태에 어떠한 영향을 미치는가?)
JiHye Lee1, kyeong Ho Lee1, SeokGi Kim1, Il Hae Park1, Hong Gil Sun1 and Youn Young Kim1.
1 Mamapapa & baby OB&GY, 1367-5 Hwashin building 4th floor Dal-dong, Nam-gu Ulsan, X, Republic of Korea, 680-805
It is still unclear whether detrimental effects of GnRH antagonist are oocyte quality or endometrial maturation. Frozen-thawed embryo transfer cycle provides a model to eliminate any detrimental effect of GnRH antagonist in the oocyte retrieval cycle. To assess whether the GnRH antagonist had a detrimental effect on embryo quality, we compared the frozen-thawed embryo transfer (FET) outcomes of GnRH agonist or GnRH antagonist protocols for COS in the previous oocyte retrieval cycle.
A retrospective study
We analyzed 559 cycles from patients underwent FETs from January 2010 to November 2012. The patients were divided into two groups based on whether they had been treated using a GnRH agonist long protocol (group A, n=331) or a GnRH antagonist protocol (group B, n=228) during the previous oocyte retrieval cycle. FETs were performed to patients either in natural cycle or in a hormonally manipulated artificial cycle following preparation of the endometrium with estradiol and progesterone. Embryos were frozen on day 3 using a vitrification protocol and FETs were performed by same physician. We compared survival rates, embryo quality, pregnancy and ongoing rates.
There were no differences between both groups in patient age (35±4.4 in group A vs. 36±3.9 in group B), endometrial thickness (9.2±2.1 vs. 9.5±1.8), fully intact rates (69.2% vs. 66.9%), and survival rates (83.6% vs. 81.3%). And numbers of good quality embryos transferred were similar for the GnRH agonist and GnRH antagonist groups(57.5% vs. 60.5%). Pregnancy and ongoing rates were 33.8% vs. 37.3% and 32.0% vs. 33.8%, respectively, which was not statistically significantly different
The use of GnRH agonists or GnRH antagonists in oocyte retrieval cycles did not result in different outcomes for frozen-thawed embryo transfer in terms of pregnancy or ongoing rates. Our results suggest that GnRH antagonists do not have a detrimental effect on embryo quality.